ERNA

1.36016.56%
SL

Sanjeev Luther

CEO, President & Director

Mr. Sanjeev Luther serves as President, Chief Executive Officer and as a Director at Ernexa Therapeutics Inc. (formerly known as Eterna Therapeutics Inc.) since January 01, 2024. He served as the Chief Executive Officer, President & Director at Cornerstone Pharmaceuticals, Inc. (formerly known as Rafael Pharmaceuticals, Inc.). since November 2017 until December 2023 and also served as Chairman of the Board since 2022 until December 2023. He had been Director at LipoMedix Pharmaceutical Inc. until 2024. Mr. Luther served as Vice President of Consulting Services at PharmARC Analytic Solutions Pvt Ltd. He has expertise in domestic and global strategic marketing, marketing insights, strategic planning/new business development and database marketing. He held senior level positions in leading healthcare companies such as Novartis and Bausch & Lomb. Prior to PharmARC, Mr. Luther served as Vice President of Marketing Science at Endo Pharmaceuticals. He served for leading pharmaceutical companies such as Bristol-Myers Squibb, GE Healthcare and Mallinckrodt Pharmaceuticals. Mr. Luther is a seasoned pharmaceutical executive having spent years in leadership roles across public and private biotechnology and global pharmaceutical companies. At Cornerstone, he also held the roles of Chief Operations Officer and Chief Business Officer since December 2014 until November 2017. Prior to Cornerstone, Mr. Luther led business-building and fundraising strategies for Fortune 500 corporations and start-ups in pharmaceuticals, biotech, medical devices and diagnostics, including Bristol-Myers Squibb, Novartis, Bausch and Lomb and GE Healthcare. He has experience across a range of therapeutic areas and stages, from R&D through commercialization. Mr. Luther holds an MBA in Marketing and a B.S. in Marketing/Business Administration from the State University of New York at Buffalo.

Positions